Skip to main content
PMC home page
Frontiers in Molecular Neuroscience logoLink to Frontiers in Molecular Neuroscience
. 2021 Dec 17;14:793004. doi: 10.3389/fnmol.2021.793004

GLP-1 Suppresses Feeding Behaviors and Modulates Neuronal Electrophysiological Properties in Multiple Brain Regions

Xin-Yi Chen 1,2, Lei Chen 3, Wu Yang 1,*, An-Mu Xie 2,*
PMCID: PMC8718614  PMID: 34975402

Abstract

The glucagon-like peptide-1 (GLP-1) plays important roles in the regulation of food intake and energy metabolism. Peripheral or central GLP-1 suppresses food intake and reduces body weight. The electrophysiological properties of neurons in the mammalian central nervous system reflect the neuronal excitability and the functional organization of the brain. Recent studies focus on elucidating GLP-1-induced suppression of feeding behaviors and modulation of neuronal electrophysiological properties in several brain regions. Here, we summarize that activation of GLP-1 receptor (GLP-1R) suppresses food intake and induces postsynaptic depolarization of membrane potential and/or presynaptic modulation of glutamatergic or GABAergic neurotransmission in brain nuclei located within the medulla oblongata, pons, mesencephalon, diencephalon, and telencephalon. This review may provide a background to guide future research about the cellular mechanisms of GLP-1-induced feeding inhibition.

Keywords: GLP-1, electrophysiological property, feeding behavior, spontaneous firing activity, synaptic transmission

Introduction

The pre-proglucagon (Gcg) gene product peptides include glucagon-like peptide 1 (GLP-1), GLP-2, oxyntomodulin (OXM), intervening peptide 1 (IP1), and glicentin. The GLP-1-producing preproglucagon (PPG) neurons located in the nucleus tractus solitarius (NTS) and the intermediate reticular nucleus of the medulla oblongata are the major source of endogenous GLP-1 in the central nervous system, which project widely throughout the central nervous system especially the autonomic control areas (Merchenthaler et al., 1999; Barrera et al., 2011; Llewellyn-Smith et al., 2011; Holt et al., 2019; Muller et al., 2019). Ablation of the PPG neurons in the NTS largely reduces the level of GLP-1 in the hypothalamus, brainstem, and spinal cord (Holt et al., 2019). In addition to the central source, peripheral GLP-1 is released from enteroendocrine L-cells in intestinal mucosa (Eissele et al., 1992) which plays an important role in regulating glucose homeostasis (Edwards et al., 1999; Williams, 2009). Furthermore, a small population of PPG neurons has been identified within the olfactory bulb with only local projection (Thiebaud et al., 2016). Central GLP-1 binds to GLP-1 receptor (GLP-1R) to exert many important effects including modulation of energy balance, cardiovascular system, learning and memory, rewarding effect of food, and thermogenesis (Trapp and Cork, 2015). GLP-1R belongs to G protein-coupled receptors with predominate Gαs coupling, leading to activation of adenylate cyclase and in turn increased levels of cAMP (Mayo et al., 2003). GLP-1R expressing cells are widely expressed in mouse and non-human primate brain (Cork et al., 2015; Heppner et al., 2015). Recent immunocytochemistry revealed the distribution and subcellular localization of GLP-1R in rat brain (Farkas et al., 2021).

GLP-1 is involved in the regulation of food intake and energy metabolism. Both human clinical trials and animal experiments demonstrated that peripheral or central GLP-1 and GLP-1 analogs suppress food intake and reduce body weight (Turton et al., 1996; Hayes et al., 2008, 2011; Dossat et al., 2011; Heppner and Perez-Tilve, 2015). A recent study revealed that central and peripheral GLP-1 inhibits feeding behaviors through independent gut-brain circuits (Brierley et al., 2021). Activation of GLP-1R in a variety of brain regions, including the hypothalamus (Schick et al., 2003), mesolimbic system (Dossat et al., 2011; Alhadeff et al., 2012; Dickson et al., 2012), and hindbrain (Hayes et al., 2011; Alhadeff et al., 2014), reduces food intake. Drugs targeting GLP-1R have been used as weight loss and anti-diabetic glucose-lowering therapies (Heppner and Perez-Tilve, 2015).

The brain is the most intricate network structure which facilitates a concerted communication between single neurons, different neuronal populations, and remote brain (Gupta et al., 2020). Neurons are the basic structural and functional units in the central nervous system. The electrophysiological properties of neurons such as the spontaneous firing activities and the synaptic neurotransmission in the mammalian central nervous system reflect the neuronal excitability and the functional organization of the brain (Llinás, 1989, 2014). To date, measuring the electrophysiological features of neurons remains one of the most valuable methods to study the functional phenomena of the nervous system. The specific deficits of the electrophysiological properties contribute to some brain diseases (Bernard and Shevell, 2008; Klassen et al., 2011; Tai et al., 2014). Therefore, manipulation of the electrophysiological properties including the spontaneous firing activity of central neurons may play roles in the manifestation of some neurological disorders. For example, the electrophysiological characteristics of dopaminergic neurons in the substantia nigra pars compacta change before the appearance of motor symptoms in parkinsonian mice (Qi et al., 2017), while excitatory stimulation of dopaminergic neurons may improve the survival of the neurons (Michel et al., 2013). Many studies have demonstrated that GLP-1 suppresses feeding behaviors and modulates the spontaneous firing activities and/or glutamatergic or GABAergic neurotransmission in multiple brain regions. This review highlights the activation of GLP-1R-induced suppression of feeding as well as the modulation of neuronal electrophysiological properties of several brain regions in medulla oblongata, pons, mesencephalon, diencephalon, and telencephalon.

Medulla Oblongata and Pons

The medullar oblongata in rodents and monkeys expresses a high level of GLP-1R (Merchenthaler et al., 1999; Cork et al., 2015; Heppner et al., 2015; Farkas et al., 2021). In human brain tissue of autopsies, GLP-1R is also expressed in the medullar oblongata including the area postrema, the dorsal motor nucleus of the vagus, and the NTS (Farr et al., 2016). GLP-1 modulates feeding behaviors in the medullar oblongata. Recently, Gaykema et al. (2017) reported that selectively chemogenetic stimulation of caudal medulla pre-proglucagon-producing neurons reduces food intake in both fed and fasted states and suppresses glucose production. Patch-clamp electrophysiological recordings in brain slices further demonstrated that chemogenetic activation selectively depolarizes neuronal membrane potential and increases the firing frequency of labeled medulla pre-proglucagon-producing neurons without affecting unlabeled neurons.

The NTS is the main source of endogenous GLP-1 within the brain (Barrera et al., 2011; Holt et al., 2019). Application of the stable GLP-1R analog exendin-4 into the medial subnucleus of the NTS (mNTS) reduces high-fat diet intake (Alhadeff and Grill, 2014; Table 1). However, electrophysiological studies revealed that GLP-1 or exendin-4 does not change the spontaneous firing activity as well as the synaptic transmission suggesting lack of functional GLP-1R in PPG neurons (Hisadome et al., 2010). Consistent with the electrophysiological results, the morphological study showed a weak/faint expression of GLP-1R in the NTS. It is reported that astrocytes in NTS are components of the GLP-1 signaling system which is involved in food intake control (Reiner et al., 2016). Intracerebroventricular application of GLP-1R agonist binds to GLP-1R on both neurons and astrocytes in the NTS. Activation of GLP-1R induces an increase in intracellular Ca2+ in 40% of NTS astrocytes, while selective inhibition of astrocyte function in NTS abolishes exendin-4-induced inhibition of food intake (Reiner et al., 2016). Therefore, complex mechanisms in both neurons and astrocytes may be involved in GLP-1-induced modulation of food intake in the NTS.

TABLE 1.

Activation of GLP-1R suppresses feeding behaviors and modulates neuronal electrophysiological properties in several brain nuclei.

Brain regions Neurons Associated effects in feeding behaviors
 Electrophysiological effects of activating GLP-1R GLP-1R agonists References
Activation of GLP-1R Ablation of GLP-1R
mNTS PPG neurons Reduction of high-fat diet intake N/A No change in firing activity and synaptic transmission Exendin-4
GLP-1		 Hisadome et al., 2010; Alhadeff and Grill, 2014
PBN Unidentified neurons Reduction of food intake and body weight N/A Increase in firing rate Exendin-4 Richard et al., 2014
VTA DAergic VTA-to-NAc projection neurons Suppression of high-fat food intake N/A Increase of sEPSCs frequency
Inhibition of mEPSCs		 Exendin-4 Mietlicki-Baase et al., 2013;
Wang et al., 2015
ARC POMC neurons N/A N/A Depolarization and increase in firing rate via TRPC5 channels
Increase of EPSCs frequency		 Liraglutide Secher et al., 2014; He et al., 2019
NPY/AgRP neurons N/A N/A Hyperpolarization via enhanced GABAA receptor-mediated neurotransmission Liraglutide Secher et al., 2014; He et al., 2019
Kisspeptin (Kiss1)-expressing neurons N/A N/A Depolarization and increase in firing rate Liraglutide Heppner et al., 2017
PVN Unidentified neurons Reduction of food intake Increase of food intake and induction of obesity Hyperpolarization via enhancement of inhibitory postsynaptic transmission
Depolarization or inward current accompanied by an increase in membrane conductance		 Exendin-4
GLP-1		 Larsen et al., 1997; McMahon and Wellman, 1998; Acuna-Goycolea and van den Pol, 2004; Cork et al., 2015
CRH neurons N/A N/A Enhancement of EPSC amplitude Liu et al., 2017
LH Orexinergic neurons N/A N/A Depolarization and increase in firing rate postsynaptically via sodium-dependent non-specific cationic conductance
Enhancement of both glutamatergic and GABAergic neurotransmission presynaptically		 Exendin-4 Acuna-Goycolea and van den Pol, 2004
PVT Unidentified neurons Reduction of food intake
Decrease of food-seeking and food-motivated behaviors		 N/A Decrease in firing rate probably via suppression of glutamatergic synaptic transmission Exendin-4 Ong et al., 2017
NAc MSNs Suppression of food intake N/A Reduction of evoked action potential postsynaptically
Increase of mEPSCs frequency presynaptically		 Exendin-4 Dossat et al., 2011; Mietlicki-Baase et al., 2014
BNST Unidentified neurons Food suppression during the dark phase N/A Inward current and depolarization accompanied by an increase in membrane conductance
Increase or decrease in firing rate
Hyperpolarization probably via opening of potassium channels		 GLP-1 Cork et al., 2015
Williams et al., 2018
HC CA1 neurons Reduction of food intake and body weight Increase of food motivated behaviors Increase and then decrease in firing activity Active fragment of GLP-1, GLP-1 (7-36) amide GLP-1 Oka et al., 1999; Hsu et al., 2015, 2018
Depolarization in most hippocampal neurons, and hyperpolarization in a few neurons Cork et al., 2015; Gullo et al., 2017
OB MCs N/A N/A Increase of the excitability probably via inhibition of voltage-dependent potassium channel GLP-1
Exendin-4		 Thiebaud et al., 2016; Schwartz et al., 2021
Open in a new tab

ARC, arcuate nucleus; BNST, bed nucleus of the stria terminalis; CRH, corticotropin-releasing hormone; EPSCs, excitatory postsynaptic currents; HC, hippocampus; LH, lateral hypothalamus; MCs, mitral cells; mEPSCs, miniature excitatory postsynaptic currents; mNTS, medial subnucleus of the nucleus tractus solitaries; MSNs, medium spiny neurons; N/A, not applicable; NAc, nucleus accumbens; NPY/AgRP, Neuropeptide Y/Agouti gene related peptide; OB, olfactory bulb; PBN, parabrachial nucleus; POMC, proopiomelanocortin; PVN, paraventricular nucleus; PVT, paraventricular thalamic nucleus; VTA, ventral tegmental area.

The parabrachial nucleus (PBN) in the pons is associated with the regulation of feeding behaviors. The PBN receives direct GLP-1 projections from NTS neurons (Richard et al., 2014). Stimulation of GLP-1R with exendin-4 in the PBN reduces food intake and therefore decreases body weight in rats. Electrophysiological evidence further revealed that application of exendin-4 results in a remarkable increase in the spontaneous firing rate of the PBN neurons (Richard et al., 2014; Figure 1A). Using the methods of immuno-electron microscopy, Farkas et al. (2021) recently revealed a very widespread distribution of GLP-1R fibers in rat brain suggesting the possible presynaptic effects of GLP-1R in the central nervous system. As the external part of the lateral parabrachial nucleus (LPBN) expresses the highest density of GLP-1R immunoreactive fibers (Farkas et al., 2021), further electrophysiological studies are needed to study the possible presynaptic modulation of the electrophysiological activities of the PBN neurons.

FIGURE 1.

FIGURE 1

Open in a new tab

A schematic diagram describing the major electrophysiological effects of activating GLP-1R in brain areas involved in modulation of feeding behaviors. (A) GLP-1 (including its agonists) binds to postsynaptic GLP-1R to depolarize membrane potential and/or increase firing rate in most brain regions, but hyperpolarize membrane potential in a few brain areas. Several ionic mechanisms, including non-selective cation channel, K+ channel, and TRPC5 channel, may be involved in activation of GLP-1R-induced depolarization or hyperpolarization. (B) In addition to postsynaptic receptors, GLP-1 acts on presynaptic GLP-1R to modulate both glutamatergic and GABAergic neurotransmission. ARC, arcuate nucleus; BNST, bed nucleus of the stria terminalis; Glu, glutamate; CRH, corticotropin-releasing hormone; HC, hippocampus; LH, lateral hypothalamus; NAc, nucleus accumbens; NPY/AgRP, Neuropeptide Y/Agouti gene-related peptide; OB, olfactory bulb; PBN, parabrachial nucleus; POMC, proopiomelanocortin; PVN, paraventricular nucleus; PVT, paraventricular thalamic nucleus; VTA, ventral tegmental area.

Mesencephalon

The ventral tegmental area (VTA) is a possible brain region for GLP-1-induced suppression of food intake. Functional study revealed that application of GLP-1R antagonist into the VTA attenuates peripheral application of exendin-4-induced anorectic effects (Mietlicki-Baase et al., 2013). Electrophysiological recordings revealed that exendin-4 increases the frequency of spontaneous excitatory postsynaptic currents (sEPSCs) of VTA dopaminergic neurons suggesting the possible presynaptic modulation of GLP-1R on glutamatergic terminals. Behavioral study also demonstrated that modulating AMPA/kainite, but not NMDA, receptor-mediated glutamatergic neurotransmission within VTA is involved in GLP-1-induced intake-suppressive effects (Mietlicki-Baase et al., 2013). In addition, intra-VTA application of exendin-4 suppresses high-fat food intake, which is consistent with the results of chemogenetic activation of endogenously released GLP-1 nerve terminals in the VTA (Wang et al., 2015). In contrast to the enhancement of spontaneous excitatory postsynaptic transmission (Mietlicki-Baase et al., 2013), using retrograde labeling of VTA to nucleus accumbens (NAc) medial shell projecting neurons, in vitro patch-clamp recordings showed that exendin-4 selectively inhibits the miniature excitatory postsynaptic currents (mEPSCs) within the dopaminergic VTA-to-NAc projection neurons (Wang et al., 2015; Figure 1B) suggesting the presynaptic inhibition of glutamatergic neurotransmission. As NAc is also an important brain region associated with GLP-1-induced feeding suppression, further electrophysiological studies are necessary to explore the contribution of glutamatergic neurotransmission to endogenously released GLP-1-induced suppression of high-fat food intake in the VTA.

Diencephalon

The arcuate nucleus (ARC) of the hypothalamus plays a particularly important role in the central regulation of food intake (Bouret et al., 2004). Two distinct types of neurons within the ARC, proopiomelanocortin (POMC) and Neuropeptide Y (NPY)/Agouti gene-related peptide (AgRP) neurons, play important roles in energy balance and glucose homeostasis (Gautron et al., 2015; Caron et al., 2018). Activation of both the NPY/AgRP neurons and POMC neurons coordinates the activity of the paraventricular nucleus (PVN), promoting stimulation or inhibition of feeding, respectively. It is well known that the anti-diabetic drug, long-acting GLP-1R agonist, liraglutide reduces body weight. The highest level of GLP-1R expressing cells, detected by transgene expression (Cork et al., 2015), in situ hybridization (Merchenthaler et al., 1999; Heppner et al., 2015), and immunocytochemistry (Farkas et al., 2021), is present in the ARC. In vitro patch-clamp electrophysiological recordings revealed that modulating the electrophysiological properties of both POMC and cocaine- and amphetamine-regulated transcript (CART) neurons (POMC/CART neurons) and NPY/AgRP neurons are the possible mechanism of liraglutide-induced weight loss (Secher et al., 2014). Peripheral application of fluorescently labeled liraglutide binds GLP-1R within the ARC (Secher et al., 2014). Liraglutide depolarizes membrane potential and increases the spontaneous action potentials directly through postsynaptic GLP-1R in the ARC neurons expressing POMC (Secher et al., 2014; He et al., 2019). In peripheral pancreatic β cells, GLP-1 depolarizes membrane potential through activation of Na+-permeable TRPM4 and TRPM5 channels (Shigeto et al., 2015). Similarly, TRPC5 channels are involved in liraglutide-induced postsynaptic excitation of arcuate neurons (He et al., 2019). In addition to perikarya and dendrites expression, high level of GLP-1R was also observed in axons of ARC neurons (Farkas et al., 2021). Consistently, electrophysiological recordings showed that liraglutide increases the EPSCs frequency of POMC neurons suggesting the modulation of presynaptic excitatory synaptic transmission (He et al., 2019).

GABA released by the NPY/AgRP neurons is very important to the control of food intake probably via inhibiting the anorectic effects of the POMC neurons. Further electrophysiological study showed that, opposite to the effects on arcuate POMC neurons, GLP-1 hyperpolarizes arcuate NPY neurons indirectly via increased GABAA receptor-mediated neurotransmission of local GABAergic interneurons (Secher et al., 2014; He et al., 2019). The Kisspeptin (Kiss1)-expressing neurons located in the ARC are responsible for gonadotropin-releasing hormone (GnRH)/luteinizing hormone (LH) release (Li et al., 2009; Han et al., 2015). The Kiss1 neurons may be a key integrator of metabolic status with GnRH/LH release. Liraglutide increases the action potential firing and causes a direct membrane depolarization of ARC Kiss1 cells in brain slices (Heppner et al., 2017).

Morphological studies demonstrated a particularly high density of GLP-1R expression in the PVN of mice (Cork et al., 2015), rats (Merchenthaler et al., 1999; Farkas et al., 2021), and primates (Heppner et al., 2015). Early study showed that exendin-4 induces diverse responses including depolarization, hyperpolarization, and no response in paraventricular hypothalamic neurons. The GLP-1-induced hyperpolarization of PVN neurons may be induced by an enhancement of inhibitory postsynaptic transmission (Acuna-Goycolea and van den Pol, 2004). Consistent with exendin-4-induced depolarization, Cork et al. (2015) also revealed that bath application of GLP-1 induces an inward current which is accompanied by an increase in membrane conductance. Activation of GLP-1R with exendin-4 enhances the amplitude but not the frequency of AMPA receptor-mediated EPSCs in PVN corticotropin-releasing hormone (CRH) neurons and thus promotes the excitability of CRH neurons postsynaptically (Liu et al., 2017). Functional studies revealed that activation of GLP-1R in the PVN reduces food intake (Larsen et al., 1997; McMahon and Wellman, 1998). Consistently, postnatal depletion of GLP-1R in the PVN increases food intake and induces obesity (Liu et al., 2017).

Different neural circuits have been proposed to maintain energy homeostasis. Both central GLP-1 and orexin pathways play an important role in neural integration of satiation and food reward. GLP-1 projections from NTS to NAc and VTA promote satiation and reduce food reward, while orexinergic projection from lateral hypothalamus to NTS suppresses satiation and increases food reward (Dossat et al., 2011). Early study revealed a direct modulation of GLP-1R on the electrophysiological activities of orexinergic neurons in the lateral hypothalamus. Application of exendin-4 depolarizes the membrane potential and increases the spontaneous discharge rate of orexinergic neurons in the lateral hypothalamus (Acuna-Goycolea and van den Pol, 2004). The GLP-1-induced excitation of orexinergic neurons is a directly postsynaptic effect that may be mediated by sodium-dependent non-specific cationic conductances. In addition, activation of GLP-1R enhances both glutamatergic and GABAergic neurotransmission presynaptically in orexinergic neurons. However, exendin-4 does not change the membrane potential as well as the firing rate of melanin-concentrating hormone (MCH) neurons in the lateral hypothalamus (Acuna-Goycolea and van den Pol, 2004). The GLP-1R activation-induced both postsynaptic and presynaptic modulation of orexinergic neurons may suggest some complex integration of satiation and food reward.

The paraventricular thalamic nucleus (PVT) neurons receive GLP-1 innervation from NTS and express GLP-1R (Cork et al., 2015; Farkas et al., 2021). PVT is involved in energy balance and reward control. Behavioral tests showed that intra-PVT application of exendin-4 reduces food intake and decreases food-seeking and food-motivated behaviors (Ong et al., 2017). Further electrophysiological recordings revealed that exendin-4 inhibits the spontaneous action potential firing in PVN neurons projecting to NAc core. Suppression of glutamatergic synaptic transmission may be associated with the reduced excitability of GLP-1R activation (Ong et al., 2017).

Telencephalon

Moderate density of GLP-1R is expressed in both the cell bodies and fibers of the NAc shell and core (Cork et al., 2015; Heppner et al., 2015; Farkas et al., 2021). Activation of GLP-1R in NAc core induces suppression of food intake (Dossat et al., 2011; Mietlicki-Baase et al., 2014). Current-clamp recordings illustrated that exendin-4 induces a small reduction in evoked action potential from medium spiny neurons (MSNs) suggesting slightly postsynaptic effects. In addition to perikarya expression, GLP-1R is also expressed on the processes of NAc (Farkas et al., 2021) suggesting some possibly presynaptic modulation of the NAc activity. Indeed, further electrophysiological studies demonstrated that exendin-4 predominantly activates presynaptic GLP-1R in NAc to increase the frequency of AMPA/kainate receptor-mediated mEPSCs. Therefore, the enhancement of glutamatergic AMPA/Kainate signaling is probably involved in GLP-1-induced inhibition of food intake (Mietlicki-Baase et al., 2014). In addition to modulating food intake, recent publication revealed that NAc is also a possible molecular target for GLP-1-induced addiction behaviors (Hernandez and Schmidt, 2019; Hernandez et al., 2019). Intra-NAc application of exendin-4 increases the spontaneous firing rate of MSNs in cocaine-experienced rats and reduces cocaine-seeking behavior in rats (Hernandez et al., 2019).

Morphological studies revealed that the neurons in the bed nucleus of the stria terminalis (BNST) express a high level of GLP-1R (Cork et al., 2015; Heppner et al., 2015; Farkas et al., 2021). Application of GLP-1 elicits an inward current and depolarization accompanied by an increase in membrane conductance (Cork et al., 2015). Recently, under the model of cell-attached patch-clamp recordings, Williams et al. (2018) reported that GLP-1 induces either an increase or a decrease of spontaneous firing rate in GLP-1R expressing BNST neurons. Further whole-cell patch-clamp recordings revealed that GLP-1 induces either a depolarizing or hyperpolarizing response, while dopamine evokes response in a reciprocal fashion to that of GLP-1. The GLP-1-induced hyperpolarization is accompanied by an increase in membrane conductance suggesting the opening of potassium channels (Williams et al., 2018). In addition, functional study demonstrated that local injection of GLP-1 into the BNST induces food suppression during the dark phase (Williams et al., 2018).

Inconsistent distribution patterns of GLP-1R in the hippocampus have been reported by different morphological studies (Cork et al., 2015; Jensen et al., 2018; Farkas et al., 2021). For example, a relatively high level of GLP-1R-immunoreactivity was observed in mouse hippocampus (Jensen et al., 2018) while a low level of GLP-1R-immunoreactivity was revealed in rat hippocampus (Farkas et al., 2021), which may suggest some species difference of the GLP-1R expression in the hippocampus. However, functional studies did detect the effects of GLP-1R in the hippocampus. Early in vivo electrophysiological recordings showed that juxtacellular application of the active fragment of GLP-1, GLP-1 (7–36) amide induces an increase and then a decrease of firing activity in the hippocampal CA1 neurons. Modulation of non-NMDA glutamate receptor-mediated synaptic transmission is involved in GLP-1-induced effects (Oka et al., 1999). Bath application of GLP-1 induces a depolarization in most hippocampal neurons and a hyperpolarization in a few neurons (Cork et al., 2015). In addition, in vitro electrophysiological recordings further demonstrated that exendin-4 elicits an early fast excitatory response dose-dependently (Gullo et al., 2017). Consistent with the electrophysiological recordings, behavioral studies showed that activation of GLP-1R in the ventral hippocampal CA1 regions reduces food intake and body weight, while targeted ventral CA1 GLP-1R knockdown increases food-motivated behaviors (Hsu et al., 2015, 2018). In addition to modulating feeding behaviors, GLP-1 promotes the proliferation of progenitor cells and increases immature neurons in the hippocampus and in turn reverses memory impairment (Lennox et al., 2014). Activation of GLP-1R with liraglutide improves cognition decline of db/db mice via increasing neuronal survival in the CA1, CA3, and DG regions of hippocampus (Zhang et al., 2021).

The olfactory bulb is the basic brain region responsible for olfactory information. The deep short axon cells (dSACs) in the granule cell layer (GCL) of olfactory bulb, named PPG neurons, could synthesize and release GLP-1 and in turn modulate the activity of the first-order neurons, mitral cells (MCs) which are the primary projection neurons of the olfactory bulb (Thiebaud et al., 2016). Positive expression of GLP-1R is detected in the GCL of olfactory bulb (Cork et al., 2015). Patch-clamp recordings revealed that bath application of GLP-1 or exendin-4 increases the spontaneous firing frequency and decreases the excitation threshold for MC firing in olfactory bulb. Decreasing the conductance of voltage-dependent potassium channels, Kv1.3, is the possible ionic mechanism of GLP-1-induced enhancement of MC excitability (Thiebaud et al., 2016). Recently, further studies revealed that optogenetic activation of PPG neurons in the GCL generates biphasic inhibition-excitation response in MCs. However, a single pulse light stimulation of PPG neurons produces only glutamatergic EPSCs, but not IPSCs, in granule cells. The stimulation of PPG neurons-induced glutamatergic EPSCs is much faster than that of GABAergic IPSCs in MCs. Under the condition of blocking GABAergic neurotransmission, light stimulation of PPG neurons results in an increase in the excitation of MCs suggesting the involvement of PPG neurons in shaping the MC firing patterns (Thiebaud et al., 2019). It is known that, in addition to olfactory physiology, MC activity is also associated with feeding and nutritional status (Fadool et al., 2011; Aimé et al., 2014; Thiebaud et al., 2014; Riera et al., 2017). The olfactory acuity is regulated by the metabolic state and therefore the olfactory system is a driver of feeding behavior. Enhancement of neuronal excitability of the major output neurons of the olfactory bulb via blocking voltage-dependent potassium channel reduces body weight in obese mice (Schwartz et al., 2021). Previous study suggested that chronic administration of fat in the diet impairs the spontaneous firing rate of MCs (Fadool et al., 2011), and reduces the amplitude of electro-olfactogram (EOG). Furthermore, the volume of olfactory bulb is significantly smaller in individuals with obesity and negatively correlated with body mass index (BMI) (Poessel et al., 2020). Therefore, the GLP-1-induced excitation of MCs, probably via inhibition of voltage-dependent potassium channel conductance and enhancement of glutamatergic neurotransmission, could lead to changed excitability of higher olfactory cortical as well as hypothalamic regions to change metabolic states.

Conclusion

Being a peptide involved in the regulation of food intake and energy metabolism, GLP-1 has been demonstrated to suppress food intake and reduce body weight. In this review, we provide a description of recent advances of GLP-1-induced inhibition of feeding behaviors and modulation of neuronal electrophysiological activities in multiple brain nuclei located within the medulla oblongata, pons, mesencephalon, diencephalon, and telencephalon (Table 1). Activation of GLP-1R suppresses food intake and induces postsynaptic depolarization of membrane potential (Figure 1A) and/or presynaptic modulation of glutamatergic or GABAergic neurotransmission (Figure 1B). Several ionic mechanisms such as non-selective cation channel, voltage-dependent potassium channel, and TRPC5 channel may be associated with activation of GLP-1R-induced electrophysiological effects (Figure 1A). This review may provide a rationale about the cellular mechanisms of GLP-1-induced suppression of feeding behaviors.

Author Contributions

X-YC wrote the original draft. LC revised the manuscript. WY and A-MX contributed to the conception, design, and revision of the manuscript. All authors contributed to the article and approved the submitted version.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Funding

This work was supported by grants from the National Natural Science Foundation of China (81971192, 81571225, and 31671076).

References

  1. Acuna-Goycolea C., van den Pol A. (2004). Glucagon-Like Peptide 1 Excites Hypocretin/Orexin Neurons by Direct and Indirect Mechanisms: Implications for Viscera-Mediated Arousal. J. Neurosci. 24 8141–8152. 10.1523/JNEUROSCI.1607-04.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aimé P., Palouzier-Paulignan B., Salem R., Koborssy D. A., Garcia S., Duchamp C., et al. (2014). Romestaing C, Julliard AK. Modulation of olfactory sensitivity and glucose-sensing by the feeding state in obese Zucker rats. Front. Behav. Neurosci. 8:326. 10.3389/fnbeh.2014.00326 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Alhadeff A. L., Baird J. P., Swick J. C., Hayes M. R., Grill H. J. (2014). Glucagon-like peptide-1 receptor signaling in the lateral parabrachial nucleus contributes to the control of food intake and motivation to feed. Neuropsychopharmacology 39 2233–2243. 10.1038/npp.2014.74 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Alhadeff A. L., Grill H. J. (2014). Hindbrain nucleus tractus solitarius glucagon-like peptide-1 receptor signaling reduces appetitive and motivational aspects of feeding. Am. J. Physiol. Regul. Integr. Comp. Physiol. 307 R465–R470. 10.1152/ajpregu.00179.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Alhadeff A. L., Rupprecht L. E., Hayes M. R. (2012). GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake. Endocrinology 153 647–658. 10.1210/en.2011-1443 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Barrera J. G., Jones K. R., Herman J. P., D’Alessio D. A., Woods S. C., Seeley R. J. (2011). Hyperphagia and increased fat accumulation in two models of chronic CNS glucagon-like peptide-1 loss of function. J. Neurosci. 31 3904–3913. 10.1523/JNEUROSCI.2212-10.2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bernard G., Shevell M., I (2008). Channelopathies: A Review. Pediatr. Neurol. 38 73–85. 10.1016/j.pediatrneurol.2007.09.007 [DOI] [PubMed] [Google Scholar]
  8. Bouret S. G., Draper S. J., Simerly R. B. (2004). Formation of Projection Pathways from the Arcuate Nucleus of the Hypothalamus to Hypothalamic Regions Implicated in the Neural Control of Feeding Behavior in Mice. J. Neurosci. 24 2797–2805. 10.1523/JNEUROSCI.5369-03.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Brierley D. I., Holt M. K., Singh A., de Araujo A., McDougle M., Vergara M., et al. (2021). Central and peripheral GLP-1 systems independently suppress eating. Nat. Metab. 3 258–273. 10.1038/s42255-021-00344-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Caron A., Dungan L. H. M., Castorena C. M., Fujikawa T., Lee S., Lord C. C., et al. (2018). POMC neurons expressing leptin receptors coordinate metabolic responses to fasting via suppression of leptin levels. eLife 7:e33710. 10.7554/eLife.33710 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cork S. C., Richards J. E., Holt M. K., Gribble F. M., Reimann F., Trapp S. (2015). Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain. Mol. Metab. 4 718–731. 10.1016/j.molmet.2015.07.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dickson S. L., Shirazi R. H., Hansson C., Bergquist F., Nissbrandt H., Skibicka K. P. (2012). The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors. J. Neurosci. 32 4812–4820. 10.1523/JNEUROSCI.6326-11.2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dossat A. M., Lilly N., Kay K., Williams D. L. (2011). Glucagon-Like Peptide 1 Receptors in Nucleus Accumbens Affect Food Intake. J. Neurosci. 31 14453–14457. 10.1523/JNEUROSCI.3262-11.2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Edwards C. M., Todd J. F., Mahmoudi M., Wang Z., Wang R. M., Ghatei M. A., et al. (1999). Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes 48 86–93. 10.2337/diabetes.48.1.86 [DOI] [PubMed] [Google Scholar]
  15. Eissele R., Göke R., Willemer S., Harthus H. P., Vermeer H., Arnold R., et al. (1992). Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur. J. Clin. Invest. 22 283–291. 10.1111/j.1365-2362.1992.tb01464.x [DOI] [PubMed] [Google Scholar]
  16. Fadool D. A., Tucker K., Pedarzani P. (2011). Mitral Cells of the Olfactory Bulb Perform Metabolic Sensing and Are Disrupted by Obesity at the Level of the Kv1.3 Ion Channel. PLoS One 6:e24921. 10.1371/journal.pone.0024921 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Farkas E., Szilvásy-Szabó A., Ruska Y., Sinkó R., Rasch M. G., Egebjerg T., et al. (2021). Distribution and ultrastructural localization of the glucagon-like peptide-1 receptor (GLP-1R) in the rat brain. Brain Struct. Funct. 226 225–245. 10.1007/s00429-020-02189-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Farr O. M., Sofopoulos M., Tsoukas M. A., Dincer F., Thakkar B., Sahin-Efe A., et al. (2016). GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial. Diabetologia 59 954–965. 10.1007/s00125-016-3874-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gautron L., Elmquist J. K., Williams K. W. (2015). Neural control of energy balance: translating circuits to therapies. Cell 161 133–145. 10.1016/j.cell.2015.02.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gaykema R. P., Newmyer B. A., Ottolini M., Raje V., Warthen D. M., Lambeth P. S., et al. (2017). Activation of murine pre-proglucagon–producing neurons reduces food intake and body weight. J. Clin. Invest. 127 1031–1045. 10.1172/JCI8133 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gullo F., Ceriani M., D’Aloia A., Wanke E., Constanti A., Costa B., et al. (2017). Plant Polyphenols and Exendin-4 Prevent Hyperactivity and TNF-α Release in LPS-Treated In vitro Neuron/Astrocyte/Microglial Networks. Front. Neurosci. 11:500. 10.3389/fnins.2017.00500 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Gupta P., Balasubramaniam N., Chang H. Y., Tseng F. G., Santra T. S. (2020). A Single-Neuron: Current Trends and Future Prospects. Cells 9:1528. 10.3390/cells9061528 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Han S. Y., McLennan T., Czieselsky K., Herbison A. E. (2015). Selective optogenetic activation of arcuate kisspeptin neurons generates pulsatile luteinizing hormone secretion. Proc. Natl. Acad. Sci. U S A. 112 13109–13114. 10.1073/pnas.1512243112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hayes M. R., Leichner T. M., Zhao S., Lee G. S., Chowansky A., Zimmer D., et al. (2011). Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation. Cell Metab. 13 320–330. 10.1016/j.cmet.2016.02.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hayes M. R., Skibicka K. P., Grill H. J. (2008). Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation. Endocrinology 149 4059–4068. 10.1210/en.2007-1743 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. He Z., Gao Y., Lieu L., Afrin S., Cao J., Michael N. J., et al. (2019). Direct and indirect effects of liraglutide on hypothalamic POMC and NPY/AgRP neurons – Implications for energy balance and glucose control. Mol. Metab. 28 120–134. 10.1016/j.molmet.2019.07.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Heppner K. M., Baquero A. F., Bennett C. M., Lindsley S. R., Kirigiti M. A., Bennett B., et al. (2017). GLP-1R Signaling Directly Activates Arcuate Nucleus Kisspeptin Action in Brain Slices but Does not Rescue Luteinizing Hormone Inhibition in Ovariectomized Mice During Negative Energy Balance. eNeuro 4 e198–e116. 10.1523/ENEURO.0198-16.2016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Heppner K. M., Kirigiti M., Secher A., Paulsen S. J., Buckingham R., Pyke C., et al. (2015). Expression and distribution of glucagon-like peptide1 receptor mRNA, protein and binding in the male nonhuman primate (Macaca mulatta) brain. Endocrinology 156 255–267. 10.1210/en.2014-1675 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Heppner K. M., Perez-Tilve D. (2015). GLP-1 based therapeutics: simultaneously combating T2DM and obesity. Front. Neurosci. 9:92. 10.3389/fnins.2015.00092 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Hernandez N. S., O’Donovan B., Ortinski P. I., Schmidt H. D. (2019). Activation of glucagon-like peptide-1 receptors in the nucleus accumbens attenuates cocaine seeking in rats. Addict. Biol. 24 170–181. 10.1111/adb.12583 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Hernandez N. S., Schmidt H. D. (2019). Central GLP-1 Receptors: Novel Molecular Targets for Cocaine Use Disorder. Physiol. Behav. 206 93–105. 10.1016/j.physbeh.2019.03.026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Hisadome K., Reimann F., Gribble F. M., Trapp S. (2010). Leptin Directly Depolarizes Preproglucagon Neurons in the Nucleus Tractus Solitarius: Electrical Properties of Glucagon-Like Peptide 1 Neurons. Diabetes 59 1890–1898. 10.2337/db10-0128 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Holt M. K., Richards J. E., Cook D. R., Brierley D. I., Williams D. L., Reimann F., et al. (2019). Preproglucagon Neurons in the Nucleus of the Solitary Tract Are the Main Source of Brain GLP-1, Mediate Stress-Induced Hypophagia, and Limit Unusually Large Intakes of Food. Diabetes 68 21–33. 10.2337/db18-0729 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Hsu T. M., Hahn J. D., Konanur V. R., Lam A., Kanoski S. E. (2015). Hippocampal GLP-1 receptors influence food intake, meal size, and effort-based responding for food through volume transmission. Neuropsychopharmacology 40 327–337. 10.1038/npp.2014.175 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Hsu T. M., Noble E. E., Liu C. M., Cortella A. M., Konanur V. R., Suarez A. N., et al. (2018). A hippocampus to prefrontal cortex neural pathway inhibits food motivation through glucagon-like peptide-1 signaling. Mol. Psychiatry 23 1555–1565. 10.1038/mp.2017.91 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Jensen C. B., Pyke C., Rasch M. G., Dahl A. B., Knudsen L. B., Secher A. (2018). Characterization of the glucagonlike peptide-1 receptor in male mouse brain using a novel antibody and in situ hybridization. Endocrinology 159 665–675. 10.1210/en.2017-00812 [DOI] [PubMed] [Google Scholar]
  37. Klassen T., Davis C., Goldman A., Burgess D., Chen T., Wheeler D., et al. (2011). Exome sequencing of ion channel genes reveals complex profiles confounding personal risk assessment in epilepsy. Cell 145 1036–1048. 10.1016/j.cell.2011.05.025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Larsen P. J., Tang-Christensen M., Jessop D. S. (1997). Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat. Endocrinology 138 4445–4455. 10.1210/endo.138.10.5270 [DOI] [PubMed] [Google Scholar]
  39. Lennox R., Flatt P. R., Gault V. A. (2014). Lixisenatide improves recognition memory and exerts neuroprotective actions in high-fat fed mice. Peptides 61 38–47. 10.1016/j.peptides.2014.08.014 [DOI] [PubMed] [Google Scholar]
  40. Li X. F., Kinsey-Jones J. S., Cheng Y., Knox A. M., Lin Y., Petrou N. A., et al. (2009). Kisspeptin signalling in the hypothalamic arcuate nucleus regulates GnRH pulse generator frequency in the rat. PLoS One 4:e8334. 10.1371/journal.pone.0008334 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Liu J., Conde K., Zhang P., Lilascharoen V., Xu Z., Lim B. K., et al. (2017). Enhanced AMPA receptor trafficking mediates the anorexigenic effect of endogenous glucagon like peptide-1 in the paraventricular hypothalamus. Neuron 96 897–909. 10.1016/j.neuron.2017.09.042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Llewellyn-Smith I. J., Reimann F., Gribble F. M., Trapp S. (2011). Preproglucagon neurons project widely to autonomic control areas in the mouse brain. Neuroscience 180 111–121. 10.1016/j.neuroscience.2011.02.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Llinás R. R. (1989). The intrinsic electrophysiological properties of mammalian neurons: insights into central nervous system function. Science 242 1654–1664. 10.1126/science.3059497 [DOI] [PubMed] [Google Scholar]
  44. Llinás R. R. (2014). Intrinsic electrical properties of mammalian neurons and CNS function: a historical perspective. Front. Cell Neurosci. 8:320. 10.3389/fncel.2014.00320 [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Mayo K. E., Miller L. J., Bataille D., Dalle S., Goke B., Thorens B., et al. (2003). International Union of Pharmacology. XXXV. The glucagon receptor family. Pharm. Rev. 55 167–194. 10.1124/pr.55.1.6 [DOI] [PubMed] [Google Scholar]
  46. McMahon L. R., Wellman P. J. (1998). PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats. Am. J. Physiol. 274 R23–R29. gu.1998.274.1.r23 10.1152/ajpre [DOI] [PubMed] [Google Scholar]
  47. Merchenthaler I., Lane M., Shughrue P. (1999). Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J. Comp. Neurol. 403 261–280. 10.1002/(SICI)1096-9861(19990111)403:23.0.CO [DOI] [PubMed] [Google Scholar]
  48. Michel P. P., Toulorge D., Guerreiro S., Hirsch E. C. (2013). Specific needs of dopamine neurons for stimulation in order to survive: implication for Parkinson disease. FASEB. J. 27 3414–3423. 10.1096/fj.12-220418 [DOI] [PubMed] [Google Scholar]
  49. Mietlicki-Baase E. G., Ortinski P. I., Reiner D. J., Sinon C. G., McCutcheon J. E., Pierce R. C., et al. (2014). Glucagon-like peptide-1 receptor activation in the nucleus accumbens core suppresses feeding by increasing glutamatergic AMPA/kainate signaling. J. Neurosci. 34 6985–6992. 10.1523/JNEUROSCI.0115-14.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Mietlicki-Baase E. G., Ortinski P. I., Rupprecht L. E., Olivos D. R., Alhadeff A. L., Pierce R. C., et al. (2013). The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors. Am. J. Physiol. Endocrinol. Metab. 305 E1367–E1374. 10.1152/ajpendo.00413.2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Muller T. D., Finan B., Bloom S. R., D’Alessio D., Drucker D. J., Flatt P. R., et al. (2019). Glucagon-like peptide 1 (GLP-1). Mol. Metab. 30 72–130. t.2019.09.010 10.1016/j.molme [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Oka J. I., Goto N., Kameyama T. (1999). Glucagon-like peptide-1 modulates neuronal activity in the rat’s hippocampus. Neuroreport 10 1643–1646. 10.1097/00001756-199906030-00004 [DOI] [PubMed] [Google Scholar]
  53. Ong Z. Y., Liu J. J., Pang Z. P., Grill H. J. (2017). Paraventricular Thalamic Control of Food Intake and Reward: Role of Glucagon-Like Peptide-1 Receptor Signaling. Neuropsychopharmacology 42 2387–2397. 10.1038/npp.2017.150 [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Poessel M., Breuer N., Joshi A., Pampel A., Villringer A., Hummel T., et al. (2020). Reduced Olfactory Bulb Volume in Obesity and Its Relation to Metabolic Health Status. Front. Hum. Neurosci. 14:586998. 10.3389/fnhum.2020.586998 [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Qi C., Varga S., Oh S. J., Lee C. J., Lee D. (2017). Optogenetic rescue of locomotor dysfunction and dopaminergic degeneration caused by alpha-synuclein and EKO genes. Exp. Neurobiol. 26 97–103. 10.5607/en.2017.26.2.97 [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Reiner D. J., Mietlicki-Baase E. G., McGrath L. E., Zimmer D. J., Bence K. K., Sousa G. L., et al. (2016). Astrocytes regulate GLP-1 receptor-mediated effects on energy balance. J. Neurosci. 36 3531–3540. 10.1523/JNEUROSCI.3579-15.2016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Richard J. E., Farkas I., Anesten F., Anderberg R. H., Dickson S. L., Gribble F. M., et al. (2014). GLP-1 Receptor Stimulation of the Lateral Parabrachial Nucleus Reduces Food Intake: Neuroanatomical, Electrophysiological, and Behavioral Evidence. Endocrinology 155 4356–4367. 10.1210/en.2014-1248 [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Riera C. E., Tsaousidou E., Halloran J., Follett P., Hahn O., Pereira M. M. A., et al. (2017). The sense of smell impacts metabolic health and obesity. Cell Metab. 26 198–211. 10.1016/j.cmet.2017.06.015 [DOI] [PubMed] [Google Scholar]
  59. Schick R. R., Zimmermann J. P., vorm Walde T., Schusdziarra V. (2003). Peptides that regulate food intake: glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284 R1427–R1435. 10.1152/ajpregu.00479.2002 [DOI] [PubMed] [Google Scholar]
  60. Schwartz A. B., Kapur A., Huang Z., Anangi R., Spear J. M., Stagg S., et al. (2021). Olfactory bulb targeted QD bioconjugate and Kv1.3 blocking peptide improve metabolic health in obese male mice. J. Neurochem. 157 1876–1896. 10.1111/jnc.15200 [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Secher A., Jelsing J., Baquero A. F., Hecksher-Sørensen J., Cowley M. A., Dalbøge L. S., et al. (2014). The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss. J. Clin. Invest. 124 4473–4488. 10.1172/JCI75276 [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Shigeto M., Ramracheya R., Tarasov A. I., Cha C. Y., Chibalina M. V., Hastoy B., et al. (2015). GLP-1 stimulates insulin secretion by PKC-dependent TRPM4 and TRPM5 activation. J. Clin. Invest. 125 4714–4728. 10.1172/JCI81975 [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Tai C., Abe Y., Westenbroek R. E., Scheuer T., Catterall W. A. (2014). Impaired excitability of somatostatin- and parvalbumin-expressing cortical interneurons in a mouse model of Dravet syndrome. Proc. Natl. Acad. Sci. U S A. 111 E3139–E3148. 10.1073/pnas.1411131111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Thiebaud N., Gribble F., Reimann F., Trapp S., Fadool D. A. (2019). A unique olfactory bulb microcircuit driven by neurons expressing the precursor to glucagon-like peptide 1. Sci. Rep. 9:15542. 10.1038/s41598-019-51880-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Thiebaud N., Johnson M. C., Butler J. L., Bell G. A., Ferguson K. L., Fadool A. R., et al. (2014). Hyperlipidemic diet causes loss of olfactory sensory neurons, reduces olfactory discrimination, and disrupts odor-reversal learning. J. Neurosci. 34 6970–6984. 10.1523/JNEUROSCI.3366-13.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Thiebaud N., Llewellyn-Smith I. J., Gribble F., Reimann F., Trapp S., Fadool D. A. (2016). The incretin hormone glucagon−like peptide 1 increases mitral cell excitability by decreasing conductance of a voltage−dependent potassium channel. J. Physiol. 594 2607–2628. 10.1113/JP272322 [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Trapp S., Cork S. C. (2015). PPG neurons of the lower brain stem and their role in brain GLP-1 receptor activation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 309 R795–R804. 10.1152/ajpregu.00333.2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Turton M. D., O’Shea D., Gunn I., Beak S. A., Edwards C. M., Meeran K., et al. (1996). A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379 69–72. 10.1038/379069a0 [DOI] [PubMed] [Google Scholar]
  69. Wang X. F., Liu J. J., Xia J., Liu J., Mirabella V., Pang Z. P. (2015). Endogenous Glucagon-like peptide-1 suppresses high-fat food intake by reducing synaptic drive onto mesolimbic dopamine neurons. Cell Rep. 12 726–733. 10.1016/j.celrep.2015.06.062 [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Williams D. L. (2009). Minireview: finding the sweet spot: peripheral versus central glucagon-like peptide 1 action in feeding and glucose homeostasis. Endocrinology 150 2997–3001. 10.1210/en.2009-0220 [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Williams D. L., Lilly N. A., Edwards I. J., Yao P., Richards J. E., Trapp S. (2018). GLP-1 action in the mouse bed nucleus of the stria terminalis. Neuropharmacology 131 83–95. 10.1016/j.neuropharm.2017.12.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Zhang H., Chu Y., Zheng H., Wang J., Song B., Sun Y. (2021). Liraglutide improved the cognitive function of diabetic mice via the receptor of advanced glycation end products down-regulation. Aging 13 525–536. 10.18632/aging.202162 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Frontiers in Molecular Neuroscience are provided here courtesy of Frontiers Media SA

RESOURCES